Standard Biotools (LAB) Cash & Equivalents Growth (1y) (2011 - 2026)
Powered by 
Analysis
Standard Biotools (LAB) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | -11.19% |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | 47.04% |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 14.53% |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | 11.35% |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | 3.13% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 63.22% |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 39.99% |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | 14.33% |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | 26.35% |
| 10 | Standard Biotools | 285.26 Mn | -191.45 Mn | 10.54 Mn | 67.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67.51% |
| Mar 31, 2026 | 73.17% |
| Dec 31, 2025 | -28.41% |
| Sep 30, 2025 | -38.94% |
| Jun 30, 2025 | -40.54% |
| Mar 31, 2025 | -46.78% |
| Dec 31, 2024 | 221.56% |
| Sep 30, 2024 | 163.44% |
| Jun 30, 2024 | 89.45% |
| Mar 31, 2024 | 151.92% |
| Dec 31, 2023 | -36.23% |
| Sep 30, 2023 | 31.42% |
| Jun 30, 2023 | 89.84% |
| Mar 31, 2023 | 269.23% |
| Dec 31, 2022 | 179.38% |
| Sep 30, 2022 | 101.86% |
| Jun 30, 2022 | 7,319.00% |
| Mar 31, 2022 | -38.93% |
| Dec 31, 2021 | -57.62% |
| Sep 30, 2021 | -58.66% |